XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

levocetirizine dihydrochloride, Quantity: 5 mg

Dostępny od:

UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia

INN (International Nazwa):

levocetirizine dihydrochloride

Forma farmaceutyczna:

Tablet, film coated

Skład:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 400

Droga podania:

Oral

Sztuk w opakowaniu:

1, 28, 30, 2, 10, 7

Typ recepty:

(S2) Pharmacy Medicine

Wskazania:

Xyzal tablets are indicated for the symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis) and chronic idiopathic urticaria.

Podsumowanie produktu:

Visual Identification: White to off white, oval film-coated tablet with Y logo on one side.; Container Type: Blister Pack; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2008-03-06